Starpharma Holdings Limited (SPL.AX)
ASX - ASX Delayed price. Currency in AUD
Add to watchlist
At close: 04:11PM AEDT
| Previous close | 0.5100 |
| Open | 0.5050 |
| Bid | 0.5100 x 334700 |
| Ask | 0.5200 x 1317400 |
| Day's range | 0.5050 - 0.5250 |
| 52-week range | 0.4900 - 1.3750 |
| Volume | |
| Avg. volume | 589,856 |
| Market cap | 208.515M |
| Beta (5Y monthly) | 1.04 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0440 |
| Earnings date | 20 Feb 2023 - 24 Feb 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 25 Mar 1988 |
| 1y target est | 0.95 |
- Simply Wall St.
Shareholders May Be More Conservative With Starpharma Holdings Limited's (ASX:SPL) CEO Compensation For Now
Shareholders of Starpharma Holdings Limited ( ASX:SPL ) will have been dismayed by the negative share price return over...
- PR Newswire
VIRALEZE Nasal Spray to be distributed in Hong Kong and Macau
An antiviral barrier nasal spray called VIRALEZE™ will launch in Hong Kong and Macau in the coming weeks, following a recent sales and distribution agreement between the product's developer Starpharma and Hengan Pharmacare Company Limited, a subsidiary of Hengan International Group Company Limited.
- Simply Wall St.
Starpharma Holdings Limited (ASX:SPL) is a favorite amongst institutional investors who own 53%
To get a sense of who is truly in control of Starpharma Holdings Limited ( ASX:SPL ), it is important to understand the...
© 2022 Yahoo. All rights reserved.
